Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’

Detalles Bibliográficos
Autores principales: Takada, K., Takamori, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547230/
https://www.ncbi.nlm.nih.gov/pubmed/36208495
http://dx.doi.org/10.1016/j.esmoop.2022.100599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547230/
https://www.ncbi.nlm.nih.gov/pubmed/36208495
http://dx.doi.org/10.1016/j.esmoop.2022.100599

Ejemplares similares